FundingWatcher
Home / Startups / Top biotech startups / Biotech startups that raised Series C / Biotech startups that raised Series C in Guangdong, China

Biotech startups that raised Series C in Guangdong, China

Updated 16 Nov 2026

Reset
Biotech startups that raised Series C in Guangdong, China
One-time CSV
  • 29 funded companies, 21 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech--series-c~guangdong-china.csv29 rows × 18 columns
CompanyCityLast roundAmountDate
Shengqiang TechnologyShenzhenSeries C$13.7M2026-07-26
Tianchen BiotechnologyTianjinSeries C$27.8M2025-06-03
Shanhai InnovationShenzhenSeries C$13.7M2025-04-16
Zhiyi PharmaceuticsGuangzhouSeries C$13.8M2024-03-28
Canton BiologicsGuangzhouSeries C$41.3M2023-09-13

5 rows of the CSV in 5 of its 18 columns.

29
Startups
$662.1M
Total raised
4
Funded in the last 12 months
$64.7M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

4 of 29
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
Shengqiang Technology Shengqiang Technology researches, manufactures, and sells high-tech products. Biotech Shenzhen Series C $13.7M 2026-07-26 $13.7M SDIC Venture Capital 101 to 250 2013
Tianchen Biotechnology Tianchen Biotechnology develops and sells medical products for ophthalmology. Biotech Tianjin Series C $27.8M 2025-06-03 $41.7M CMB International Capital Corporation 2018
Zhiyi Pharmaceutics Zhiyi Pharmaceutics researches and develops second-generation probiotics and live biotherapeutics. Biotech Guangzhou Series C $13.8M 2024-03-28 Shenzhen Capital Group, SDIC Venture Capital, Sinoking Capital 51 to 100 2013
Canton Biologics Canton Biologics provides biologics contract development and manufacturing outsourcing services. Biotech Guangzhou Series C $41.3M 2023-09-13 $41.7M SDIC Venture Capital, Rongtuo Capital Management, Taipu Life Sciences Investment 101 to 250 2016

Table 1. Biotech startups that raised Series C in Guangdong, China: the 4 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 29.

Largest rounds

Last 12 months
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 Shengqiang Technology Shengqiang Technology researches, manufactures, and sells high-tech products. Biotech Shenzhen Series C $13.7M 2026-07-26 $13.7M SDIC Venture Capital 101 to 250 2013

Table 2. Biotech startups that raised Series C in Guangdong, China: the 1 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 SDIC Venture Capital Venture capital firm Xicheng, China 3 10% 1 Shengqiang Technology
2 Shenzhen Guozhong Venture Capital Management Venture capital firm Shenzhen, China 2 7%
3 CMB International Capital Corporation Investment bank Central, Hong Kong 1 3%
4 Hongtai Capital Holdings Private equity firm Beijing, China 1 3%
5 Hongtai Fund Private equity firm Shenzhen, China 1 3%
6 Cowin Capital Private equity firm Shenzhen, China 1 3%
7 Oriental Fortune Capital Venture capital firm Shenzhen, China 1 3%
8 Amphora Capital Venture capital firm Beijing, China 1 3%
9 Dong Fang Rong Run Private equity firm Shenzhen, China 1 3%
10 BOC & Utrust Private Equity Fund Management Private equity firm Guangzhou, China 1 3%
11 Sinoking Capital Venture capital firm Beijing, China 1 3%
12 Shenzhen Capital Group Venture capital firm Nanshan, China 1 3%
13 CEC Capital Hedge fund Beijing, China 1 3%
14 GAINS Investment Corp. Private equity firm Kaohsiung, Taiwan 1 3%
15 Taipu Life Sciences Investment 1 3%

Table 3. Biotech startups that raised Series C in Guangdong, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 25 86% $606.7M
Hardware 1 3%
Cybersecurity 1 3%

Table 4. Biotech startups that raised Series C in Guangdong, China by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series C 29 100% $14.5M

Table 5. Biotech startups that raised Series C in Guangdong, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Guangzhou 12 41%
Shenzhen 10 34%
Tianjin 3 10%
Zhuhai 1 3%
Huangpu 1 3%
Nansha 1 3%
Longhua 1 3%

Table 6. Biotech startups that raised Series C in Guangdong, China by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
August 2026 1 25% $7.4M
July 2026 1 25% $13.7M
April 2026 1 25% $29.1M
March 2026 1 25% $14.5M

Table 7. Biotech startups that raised Series C in Guangdong, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 4 14% $64.7M
2025 4 14% $110.5M
2024 3 10% $55.1M
2023 6 21% $176.3M
2022 3 10% $53.6M
2021 4 14% $104.1M

Table 8. Biotech startups that raised Series C in Guangdong, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2020 to 2022 1 3%
2015 to 2019 16 55%
2010 to 2014 6 21%
Before 2010 6 21%

Table 9. Biotech startups that raised Series C in Guangdong, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 3 13%
11 to 50 2 9%
51 to 100 9 39%
101 to 250 5 22%
251 to 500 3 13%
501 to 1,000 1 4%

Table 10. Biotech startups that raised Series C in Guangdong, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in Guangdong, China whose last round is Series C are on the list?
29, in the file dated 16 November 2026. 4 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 29 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups that raised Series C in Guangdong, China: 29 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech at other stages in Guangdong

Other sectors that raised Series C in Guangdong

Cite: FundingWatcher, 29 biotech companies in Guangdong, China whose most recent round is Series C, 16 November 2026. https://fundingwatcher.com/startups/biotech/series-c/guangdong-china/